Variant report
Variant | esv3384298 |
---|---|
Chromosome Location | chr2:205441512-205442091 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs555897129 | chr2:205441527-205441528 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs180683248 | chr2:205441533-205441534 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs76355089 | chr2:205441578-205441579 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs559596084 | chr2:205441594-205441595 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs34425059 | chr2:205441618-205441619 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs76253364 | chr2:205441642-205441643 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs527935957 | chr2:205441648-205441649 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs544991996 | chr2:205441654-205441655 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs73057275 | chr2:205441670-205441671 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs530990022 | chr2:205441684-205441685 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs186070420 | chr2:205441687-205441688 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs1374713 | chr2:205441717-205441718 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs140375982 | chr2:205441727-205441728 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs538419335 | chr2:205441757-205441758 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs554440068 | chr2:205441758-205441759 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs528260573 | chr2:205441760-205441761 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs369723864 | chr2:205441796-205441797 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs145607830 | chr2:205441800-205441801 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs571565167 | chr2:205441822-205441823 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs115747034 | chr2:205441841-205441842 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs190243672 | chr2:205441869-205441870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs535484828 | chr2:205441894-205441895 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs553762237 | chr2:205441950-205441951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs201489327 | chr2:205442070-205442071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs61100244 | chr2:205442072-205442073 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs536308263 | chr2:205442086-205442087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Breast cancer | 21045282 | CNVD |
Papillary thyroid carcinoma | 22161024 | CNVD |
Cervical cancer | 21062161 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Prostate cancer | 16573809 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Cancer | 20164920 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:205425800-205454400 | Weak transcription | HSMM | muscle |
2 | chr2:205438800-205448600 | Weak transcription | Left Ventricle | heart |
3 | chr2:205438800-205458000 | Weak transcription | Gastric | stomach |
4 | chr2:205439000-205444200 | Weak transcription | Brain Cingulate Gyrus | brain |
5 | chr2:205439400-205444000 | Weak transcription | Pancreas | Pancrea |
6 | chr2:205439600-205444000 | Weak transcription | Ovary | ovary |
7 | chr2:205439600-205450600 | Weak transcription | Aorta | Aorta |
8 | chr2:205440600-205443600 | Weak transcription | Brain Substantia Nigra | brain |
9 | chr2:205441000-205446200 | Weak transcription | Fetal Intestine Small | intestine |
10 | chr2:205441000-205446400 | Weak transcription | Fetal Intestine Large | intestine |
11 | chr2:205441000-205454600 | Weak transcription | Psoas Muscle | Psoas |
12 | chr2:205441200-205441800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |